CME Disclosure Page: Hidden Cost of the Opioid Epidemic

The Hidden Costs of the Opioid Epidemic and Solutions to Fighting It

January 14, 2021 | 5:30 p.m. CST

Virtual

Registration

Click here to register for the event.

Speaker Evaluation Form

You must fill out the evaluation form and include your e-mail address to receive CME credit for completing the course.

Click here to fill out the evaluation form and once completed it will take you to the CME Reporting Form if you wish to claim credits.  CME Certificates will be emailed to you at a later date.  Thank you!

About the Mandate

The 2019 Texas Legislature passed three bills that requires physicians to complete at least two hours of CME in opioid prescribing.

Texas Medical Board Guidance

Click here to view the website.

Pain Management and the Prescription of Opioids

At least 2 of the 24 formal (CME) hours must involve the study of the following topics: 

  • best practices, alternative treatment options, and multi-modal approaches to pain management that may include physical therapy, psychotherapy, and other treatments;
  • safe and effective pain management related to the prescription of opioids and other controlled substances, including education regarding:

– standards of care;

– identification of drug-seeking behavior in patients; and

– effectively communicating with patients regarding the prescription of an opioid or other controlled substances; and prescribing and monitoring of controlled substances.

These formal hours maybe credited towards

  • the requirements for medical ethics or professional responsibility for any physician, or
  • the 10 hours of pain management continuing education required for those physicians practicing in pain clinics (see info below under “Additional Requirements”).

This requirement applies to the renewal of a license on or after September 1, 2020.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Texas Medical Association (TMA) through the joint providership of the Texas Orthopaedic Association and Trinity University. The Texas Orthopaedic Association is accredited by TMA to provide continuing medical education for physicians.

CME Designation Statement

The Texas Orthopaedic Association designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Ethics Designation Statement

This course has been designated by the Texas Orthopaedic Association for 1.0 credits of education in medical ethics and/or professional responsibility.

Pain Management and Prescription of Opioids Statement

This course has been designated by the Texas Orthopaedic Association for 1.0 credits of education in pain management and prescription of opioids.

Learning Objectives

  • Identify the history of opioid use in the United States
  • Identify the risks of prescribing opioids
  • Identify the long term costs of opioid prescribing pre- and post-operatively
  • Recognize the complications associated with opioid and mental health issues perioperatively

Course Outline

  • Case Review
  • History of opioids in the United States
  • Overview of the statistics for opioid use before and during COVID-19
  • Review of literature surrounding cost of care for opioid use pre-operatively
  • Review of long term cost issues for opioids
  • Review of literature surrounding the intersection of mental health and medical outcomes
  • Challenges and solutions for opioid use in the community

Speaker Disclosure

Adam Bruggeman, MD
Submitted on: 07/02/2020
Medtronic: Paid consultant
NovaBone: Paid consultant
SI-BONE: Paid consultant
Stryker: Paid consultant
Texas Medical Association: Board or committee member
Texas Orthopaedic Association: Board or committee member

Planner Disclosures

TOA mandates all instructors, planners, and other individuals in a position to control or influence the content of an educational activity to disclose all relevant financial relationships or affiliations during the past 12 months with any commercial interest. All identified conflicts of interest must be resolved and the education content vetted by the TOA for fair balance, scientific objectivity and appropriateness.

Ken J Kaminski, MD, FAAOS
AAOS: Board or committee member
Fusion5: Paid consultant
Texas Orthopedic Association: Board or committee member

Vinod Kumar Panchbhavi, MD, FAAOS, FACS
AAOS: Board or committee member
American Orthopaedic Foot and Ankle Society: Board or committee member
Foot and Ankle InternationalTechniques in Foot & Ankle SurgeryOrthopedia.com: Editorial or governing board
Stryker: Paid presenter or speaker
Wolters Kluwer Health – Lippincott Williams & Wilkins: Publishing royalties, financial or material support

Luis H Urrea II, MD, FAAOS
El Paso County Medical Society Executive Board: Board or committee member
Texas Medical Association Council on Socioeconomics: Board or committee member
Texas Orthopaedic Association Leadership Council: Board or committee member
Texas Orthopaedic Association PAC Board of Directors: Board or committee member
TEXPAC Board of Directors: Board or committee member

Sources for Continued Study

  1. Centers for Disease Control. “Pocket Guide: Tapering Opioids for Chronic Pain.”  Retrieved from Centers for Disease Control website: https://www.cdc.gov/drugoverdose/pdf/clinical_pocket_guide_tapering-a.pdf
  2. Davenport, S et al, “Costs and Comorbidities of Opioid Use Disorder: The Impact of Opioid Use Disorder for Patients with Chronic Medical Conditions.” Milliman White Paper, 2019.
  3. S. Department of Health and Human Services (2019, May). “Pain Management Best Practices Inter-Agency Task Force Report: Updates, Gaps, Inconsistencies, and Recommendations.” Retrieved from U.S. Department of Health and Human Services website: https://www.hhs.gov/ash/advisory-committees/pain/reports/index.html
  4. S. Food and Drug Administration (2016, August). “FDA Warns About Serious Risks and Death When Combining Opioid Pain or Cough Medicines with Benzodiazepines; Requires Its Strongest Warning.” Retrieved from U.S. Food and Drug Administration website: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-about-serious-risks-and-death-when-combining-opioid-pain-or
  5. Washington State Agency Medical Directors’ Group. “Interagency Guideline on Prescribing Opioids for Pain.” 2015: http://www.agencymeddirectors.wa.gov/Files/2015AMDGOpioidGuideline.pdf
  6. American Academy of Orthopaedic Surgeons’ Pain Relief Toolkit: https://www5.aaos.org/PainReliefToolkit/?ssopc=1